12 years ago

Green Biologics Secures £15.4 Million in Series B Funding to Expand Renewable n-Butanol Production

  • Green Biologics, an Oxford, UK-based industrial biotechnology company, raised £15.4 million in Series B funding led by Sofinnova Partners

  • The company specializes in renewable n-butanol production for various industries

  • The investment will be used to acquire assets from Central MN Ethanol Co-op, retrofitting the plant for renewable n-butanol and acetone production.

      • ProblemTechnology

      "The world is increasingly reliant on petrochemicals, which are derived from fossil fuels. This reliance contributes to climate change and environmental pollution. There's a need for sustainable alternatives to petrochemicals."

      Solution

      "Green Biologics is developing and producing renewable n-butanol, a chemical used in a wide range of applications, including paints, coatings, adhesives, inks, plastics, pharmaceuticals, food ingredients, household cleaners, and personal care products. By using a fermentation process with renewable feedstocks, they are creating a sustainable alternative to petrochemicals."

      Covered on